Skip to main content
. 2018 Mar 13;62(3):1181–1198. doi: 10.3233/JAD-170531

Table 5.

Summarization of most reported biomarkers from our studies

Biomarkers Reference number Case controls studies Biomarkers of brain atrophy and rate of cognitive decline Biomarkers of brain amyloid burden Biomarkers of CSF Aβ
clusterin 6 [36] [33], [45], [41], [43], [44] [41]
complement C3 6 [45], [41], [48], [59] [56], [58], [59]
FGG 5 [41], [48] [57], [59] [79]
APOE 4 [36] [44] [59], [56]
PPY 3 [33], [59] [59], [71]
α2M 3 [15] [57], [58]
α-1-antitrypsin 3 [45] [45], [44], [59] [59]
FCN2 3 [33] [79], Baird et al.,
unpublished
TTR 3 [41], [44], [49]

α2M, α-2-macroglobulin; FGG, γ-fibrinogen; PPY, pancreatic polypeptide; FCN2, ficolin-2; TTR, transthyretin.